8-K
Current Report
Avalo Therapeutics, Inc. Filed Acc 0001628280-23-035600
Acquisition or sale completed · Other events
- Item 2.01 Completion of acquisition or disposition of assets
- Item 8.01 Other events
From the SEC's structured data for this filing
Loading avtx-20231027.htm…